Belpointe Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.05M | Buy |
|
|||||
|
2024
Q3 | $1.02M | Sell |
|
|||||
|
2024
Q2 | $1.06M | Buy |
|
|||||
|
2024
Q1 | $826K | Sell |
|
|||||
|
2023
Q4 | $1.24M | Buy |
|
|||||
|
2023
Q3 | $317K | Sell |
|
|||||
|
2023
Q2 | $868K | Buy |
|
|||||
|
2023
Q1 | $728K | Sell |
|
|||||
|
2022
Q4 | $866K | Sell |
|
|||||
|
2022
Q3 | $1.01M | Buy |
|
|||||
|
2022
Q2 | $834K | Buy |
|
|||||
|
2022
Q1 | $448K | Sell |
|
|||||
|
2021
Q4 | $614K | Sell |
|
|||||
|
2021
Q3 | $705K | Buy |
|
|||||
|
2021
Q2 | $584K | Sell |
|
|||||
|
2021
Q1 | $2.51M | Sell |
|
|||||
|
2020
Q4 | $2.77M | Sell |
|
|||||
|
2020
Q3 | $2.78M | Sell |
|
|||||
|
2020
Q2 | $3.4M | Buy |
|
|||||
|
2020
Q1 | $1.33M | Sell |
|
|||||
|
2019
Q4 | $2.63M | Buy |
|
|||||
|
2019
Q3 | $335K | Sell |
|
|||||
|
2019
Q2 | $1.94M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $296K | Sell |
|
|||||
|
2018
Q3 | $3.56M | Sell |
|
|||||
|
2018
Q2 | $3.6M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $234K | Buy |
|